http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34029252

Outgoing Links

Predicate Object
contentType Journal Article
issn 0753-3322
pageRange 113222-
publicationName Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
startingPage 113222
bibliographicCitation Gong Q, Zhang R, Wei F, Fang J, Zhang J, Sun J, Sun Q, Wang H. SGLT2 inhibitor-empagliflozin treatment ameliorates diabetic retinopathy manifestations and exerts protective effects associated with augmenting branched chain amino acids catabolism and transportation in db/db mice. Biomed Pharmacother. 2022 Aug;152():113222. doi: 10.1016/j.biopha.2022.113222. PMID: 35671581.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41cfb320b88e5623867efb4a8e6c451f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe4065cb415c829d7d18937d561393f0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93e2d14829e98d9ea71d49ff89264830
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5783e318567cb97a3cc0f486fb912b0f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0752a0d998f3b4e72eef00a999473922
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed412f29533db475d12cef439114dc83
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c8ff8500767da6f165328ae597cac2f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb5197f20a9bcdd8f633eb8ab37f0d87
date 202208
identifier https://pubmed.ncbi.nlm.nih.gov/35671581
https://doi.org/10.1016/j.biopha.2022.113222
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1156
https://portal.issn.org/resource/ISSN/0753-3322
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title SGLT2 inhibitor-empagliflozin treatment ameliorates diabetic retinopathy manifestations and exerts protective effects associated with augmenting branched chain amino acids catabolism and transportation in db/db mice
discusses http://id.nlm.nih.gov/mesh/M000639744
http://id.nlm.nih.gov/mesh/M0000923
http://id.nlm.nih.gov/mesh/M0571248
http://id.nlm.nih.gov/mesh/M0009358
http://id.nlm.nih.gov/mesh/M0002345
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000077203Q000627
http://id.nlm.nih.gov/mesh/D000077203Q000494
http://id.nlm.nih.gov/mesh/D003930Q000188
http://id.nlm.nih.gov/mesh/D003924Q000150
http://id.nlm.nih.gov/mesh/D003924Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D001559Q000627
http://id.nlm.nih.gov/mesh/D053719
http://id.nlm.nih.gov/mesh/D008322
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D001559Q000494
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D000597
http://id.nlm.nih.gov/mesh/D005960
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4fb3b68e84149f91bcfd0102f95d3731
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6567
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f89d53127fac03812c245bc89053817
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_371ae31aace001ea532f5390d67f9844
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b13b35aadedbba932bdbce570ebfdeb8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9886134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11949646
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e4b79a848f87fb3e9d37c2780d0ad9fe
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a95245167042cebb599d71e1a81bf6d4
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3a0a7abebd663060ca3e6921ec569df7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab9bc7ce433266ca5b4543e538aeed73

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16847

Total number of triples: 63.